Amena

Amena

tibolone

Manufacturer:

BIOFEMME, Inc

Distributor:

UNILAB, Inc
Concise Prescribing Info
Contents
Tibolone
Indications/Uses
As menopausal therapy in the treatment of menopausal vasomotor symptoms & prevention of postmenopausal osteoporosis.
Dosage/Direction for Use
2.5 mg daily. Start treatment 12 mth after last menstrual bleed.
Administration
May be taken with or without food.
Contraindications
Presence or history of hormone-dependent tumors, CV or cerebrovascular disorders including thrombophlebitis, thromboembolic processes or undiagnosed vag bleeding & severe liver disorders. Prior to or w/in 12 mth of the natural menopause. Pregnancy & lactation.
Special Precautions
Liver disease; disorders exacerbated by fluid retention eg, history or known kidney dysfunction, epilepsy & migraine; hypercholesterolemia, impaired glucose tolerance. Discontinue use if signs of thromboembolism, cholestatic jaundice, abnormal liver function tests. Stop treatment 4 wk before elective surgery. W/drawal bleed should be induced w/ a progestogen prior to treatment in women transferring from another form of HRT.
Adverse Reactions
Irregular vag bleeding or spotting. Body wt changes, ankle edema, dizziness, skin reactions, headache, migraine, visual & GIU disturbances, increased growth of facial hair, altered liver function, depression, arthralgia or myalgia.
ATC Classification
G03CX01 - tibolone ; Belongs to the class of other estrogens. Used in the treatment of menopausal symptoms.
Presentation/Packing
Form
Amena tab 2.5 mg
Packing/Price
28's (P1,158/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in